• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性氧通过激活人卵巢癌细胞中的AKT和P70S6K1来调节表皮生长因子诱导的血管内皮生长因子和缺氧诱导因子-1α的表达。

Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.

作者信息

Liu Ling-Zhi, Hu Xiao-Wen, Xia Chang, He Jie, Zhou Qiong, Shi Xianglin, Fang Jing, Jiang Bing-Hua

机构信息

Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

出版信息

Free Radic Biol Med. 2006 Nov 15;41(10):1521-33. doi: 10.1016/j.freeradbiomed.2006.08.003. Epub 2006 Aug 7.

DOI:10.1016/j.freeradbiomed.2006.08.003
PMID:17045920
Abstract

The epidermal growth factor (EGF) and EGF receptor (EGFR) family are often overexpressed in various human cancers including ovarian cancer. While it is generally believed that reactive oxygen species (ROS) are involved in the intracellular signaling events, the role of ROS in EGF-induced angiogenesis and carcinogenesis remains to be elucidated. The present study investigated the role of ROS in the regulation of AKT, p70S6K1, vascular endothelial growth factor (VEGF), and hypoxia-inducible factor 1 (HIF-1) in ovarian cancer cells. In this study, OVCAR-3 cells were treated with EGF and catalase, an H2O2 scavenger. EGF treatment increases H2O2 production, leading to activation of the AKT/p70S6K1 pathway, resulting in increased VEGF expression at the transcriptional level. The inhibition of H(2)O(2) production by catalase abolished EGF-induced AKT and p70S6K1 activation, and VEGF expression through HIF-1alpha expression. Forced expression of p70S6K1 and HIF-1alpha reversed catalase- and rapamycin-inhibited VEGF transcriptional activation. We also showed that rapamycin, p70S6K1 inhibitor and catalase overexpression inhibited tumor angiogenesis. This study demonstrates a novel mechanism of EGF-induced VEGF and HIF-1alpha expression through production of H2O2 and activation of AKT and p70S6K1 in human ovarian cancer cells. This study also indicates that p70S6K1 and H2O2 are important in tumor angiogenesis. The results of the study could have an important implication in ovarian cancer therapy.

摘要

表皮生长因子(EGF)和表皮生长因子受体(EGFR)家族在包括卵巢癌在内的多种人类癌症中常常过度表达。虽然人们普遍认为活性氧(ROS)参与细胞内信号转导事件,但ROS在EGF诱导的血管生成和致癌作用中的作用仍有待阐明。本研究调查了ROS在卵巢癌细胞中对AKT、p70S6K1、血管内皮生长因子(VEGF)和缺氧诱导因子1(HIF-1)调控中的作用。在本研究中,用EGF和过氧化氢酶(一种H2O2清除剂)处理OVCAR-3细胞。EGF处理增加了H2O2的产生,导致AKT/p70S6K1途径激活,从而在转录水平上增加VEGF表达。过氧化氢酶对H2O2产生的抑制消除了EGF诱导的AKT和p70S6K1激活以及通过HIF-1α表达的VEGF表达。p70S6K1和HIF-1α的强制表达逆转了过氧化氢酶和雷帕霉素抑制的VEGF转录激活。我们还表明,雷帕霉素、p70S6K1抑制剂和过氧化氢酶过表达抑制肿瘤血管生成。本研究证明了在人卵巢癌细胞中,EGF通过产生H2O2以及激活AKT和p70S6K1诱导VEGF和HIF-1α表达的新机制。本研究还表明p70S6K1和H2O2在肿瘤血管生成中很重要。该研究结果可能对卵巢癌治疗具有重要意义。

相似文献

1
Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.活性氧通过激活人卵巢癌细胞中的AKT和P70S6K1来调节表皮生长因子诱导的血管内皮生长因子和缺氧诱导因子-1α的表达。
Free Radic Biol Med. 2006 Nov 15;41(10):1521-33. doi: 10.1016/j.freeradbiomed.2006.08.003. Epub 2006 Aug 7.
2
Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.活性氧通过激活人前列腺癌细胞中的p70S6K1来调节胰岛素诱导的VEGF和HIF-1α表达。
Carcinogenesis. 2007 Jan;28(1):28-37. doi: 10.1093/carcin/bgl085. Epub 2006 Jun 13.
3
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.咖啡因可抑制腺苷诱导的缺氧人结肠癌细胞中缺氧诱导因子-1α、血管内皮生长因子和白细胞介素-8的表达积累。
Mol Pharmacol. 2007 Aug;72(2):395-406. doi: 10.1124/mol.106.032920. Epub 2007 May 8.
4
A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.AKT对缺氧诱导因子-1的非缺氧依赖性上调促进了人胃癌的血管生成。
Carcinogenesis. 2008 Jan;29(1):44-51. doi: 10.1093/carcin/bgm232. Epub 2007 Nov 4.
5
9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤通过缺氧诱导因子-1抑制人卵巢癌细胞中血管内皮生长因子的表达。
Mol Pharmacol. 2004 Jul;66(1):178-86. doi: 10.1124/mol.66.1.178.
6
Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.蝶呤霉素通过抑制表皮生长因子受体/细胞外信号调节激酶/p70S6 激酶信号通路抑制生长因子诱导的人宫颈癌 HIF-1α 激活和肿瘤血管生成。
J Cell Biochem. 2012 Apr;113(4):1302-13. doi: 10.1002/jcb.24001.
7
4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.4-羟基雌二醇而非2-羟基雌二醇通过磷脂酰肌醇3-激酶/蛋白激酶B/脆性组氨酸三联体通路诱导OVCAR-3和A2780-CP70人卵巢癌细胞中缺氧诱导因子1α和血管内皮生长因子A的表达。
Toxicol Appl Pharmacol. 2004 Apr 1;196(1):124-35. doi: 10.1016/j.taap.2003.12.002.
8
Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells.顺铂介导人卵巢癌细胞中血管内皮生长因子表达的机制
Biochem Biophys Res Commun. 2007 Jun 22;358(1):92-8. doi: 10.1016/j.bbrc.2007.04.083. Epub 2007 Apr 20.
9
Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.阿索呋喃酮通过抑制 Akt/mTOR/p70S6K 通路抑制 EGF 诱导的 MDA-MB-231 乳腺癌细胞中 HIF-1α 蛋白的合成。
Toxicol Appl Pharmacol. 2013 Dec 15;273(3):542-50. doi: 10.1016/j.taap.2013.09.027. Epub 2013 Oct 3.
10
Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.水飞蓟宾抑制人宫颈癌细胞和肝癌细胞中的缺氧诱导因子-1α以及mTOR/p70S6K/4E-BP1信号通路:对癌症治疗的启示
Oncogene. 2009 Jan 22;28(3):313-24. doi: 10.1038/onc.2008.398. Epub 2008 Nov 3.

引用本文的文献

1
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers.癌症中的氧化应激:从肿瘤与微环境重塑到治疗前沿
Mol Cancer. 2025 Aug 22;24(1):219. doi: 10.1186/s12943-025-02375-x.
2
Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics.活性氧:癌症信号通路动力学调控中的双刃剑
Cells. 2025 Aug 6;14(15):1207. doi: 10.3390/cells14151207.
3
[Research Progress in the Role of Hypoxia-Inducible Factor 1 in Altitude Sickness and the Mechanisms Involved].
[缺氧诱导因子1在高原病中的作用及相关机制的研究进展]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1424-1435. doi: 10.12182/20241160303.
4
Reactive oxygen and nitrogen species: multifaceted regulators of ovarian activity†.活性氧和氮物种:卵巢活动的多面调节因子†
Biol Reprod. 2025 May 13;112(5):789-806. doi: 10.1093/biolre/ioaf032.
5
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of Oxidative Stress and Antioxidants.从氧化应激和抗氧化剂角度探索预防和治疗卵巢癌的策略。
Antioxidants (Basel). 2025 Jan 20;14(1):114. doi: 10.3390/antiox14010114.
6
Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research.癌症干细胞的靶向治疗:mTOR 在临床前和临床研究中的抑制作用。
Cell Death Dis. 2024 Sep 30;15(9):696. doi: 10.1038/s41419-024-07077-8.
7
The pleiotropic functions of reactive oxygen species in cancer.活性氧在癌症中的多效功能。
Nat Cancer. 2024 Mar;5(3):384-399. doi: 10.1038/s43018-024-00738-9. Epub 2024 Mar 22.
8
Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer.线粒体功能障碍途径作为人类癌症的一种可能生物标志物和治疗靶点。
Biomed J. 2025 Feb;48(1):100714. doi: 10.1016/j.bj.2024.100714. Epub 2024 Mar 5.
9
The impact of physical activity on promoter-specific methylation of genes involved in the redox-status and disease progression: A longitudinal study on post-surgery female breast cancer patients undergoing medical treatment.体力活动对参与氧化还原状态和疾病进展的基因启动子特异性甲基化的影响:对接受医学治疗的手术后女性乳腺癌患者的纵向研究。
Redox Biol. 2024 Apr;70:103033. doi: 10.1016/j.redox.2024.103033. Epub 2024 Jan 5.
10
Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview.纳米医学在卵巢癌治疗中的治疗应用解析:综述。
Curr Drug Deliv. 2024;21(9):1180-1196. doi: 10.2174/0115672018253815230922070558.